All immediate challenges to the status of abortifacient mifepristone on the US market are on ice for the near future after the Supreme Court on Apr. 21 — without...

Conflicting decisions by federal courts in Texas and Washington on separate lawsuits involving mifepristone, one of the two drugs most widely used in medication-induced...